N04.21
Primary membranous nephropathy with nephrotic syndrome
Clinical Classification Guidelines
Inclusion Terms
- Idiopathic membranous nephropathy with nephrotic syndrome
Medical Intelligence & Overview
Primary membranous nephropathy with nephrotic syndrome is a kidney disorder where the immune system mistakenly attacks the layers of tissue in the kidneys. This condition leads to damage in the glomeruli—small filtering units within the kidneys—resulting in significant protein leakage into the urine, a hallmark of nephrotic syndrome. It is considered an idiopathic condition, meaning its exact cause is often unknown, although it involves immune system activity. Individuals with this diagnosis typically experience swelling, weight gain, and other symptoms related to the loss of protein in the urine.
Causes & Symptoms
Clinical Causes: Immune system dysfunction where antibodies target the kidney's filtering structures Presence of specific autoantibodies against the phospholipase A2 receptor on kidney cells Genetic predispositions that increase susceptibility Certain infections or medications historically linked but less common in idiopathic cases Secondary causes like autoimmune diseases, cancers, or exposure to toxins are usually excluded in primary forms
Key Symptoms: Swelling (edema), especially around the eyes, ankles, and abdomen Foamy or frothy urine due to excess protein Weight gain from fluid retention Fatigue and weakness High blood pressure in some cases Reduced kidney function in progressive stages
Diagnostic & Treatment
Diagnosis Path: Diagnosing primary membranous nephropathy with nephrotic syndrome involves several steps: - **Urinalysis**: Detects high levels of protein and possible blood in the urine. - **Blood tests**: Measure serum albumin, cholesterol levels, and kidney function markers. - **Serologic tests**: Identify specific autoantibodies, such as anti-phospholipase A2 receptor antibodies. - **Kidney biopsy**: The definitive test, revealing characteristic changes consistent with membranous nephropathy, including thickened glomerular basement membranes and immune deposits. - **Exclusion of secondary causes**: Additional testing to rule out other conditions like autoimmune diseases or infections.
Treatment Protocols: Management of primary membranous nephropathy with nephrotic syndrome aims to reduce proteinuria, control symptoms, and slow kidney damage. Approaches include: - **Medications**: - *Immunosuppressive therapies*: corticosteroids, cyclophosphamide, or rituximab to dampen immune activity. - *Blood pressure medications*: ACE inhibitors or angiotensin II receptor blockers to decrease protein leakage and protect kidney function. - *Diuretics*: to reduce edema. - *Lipid-lowering agents*: to manage high cholesterol levels associated with nephrotic syndrome. - **Lifestyle modifications**: - Low-sodium diet to control swelling. - Adequate protein intake adjusted based on kidney function. - Regular monitoring of blood pressure and kidney function. - **Follow-up care**: - Routine assessments to evaluate response to therapy. - Monitoring for potential side effects of medications. - Adjustments to treatment plans based on disease progression or remission.
Clinical Advice & FAQs
Billing Guidance
Is N04.21 a billable ICD-10 code?
Yes, N04.21 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N04.21?
Clinical documentation must specify the nature of Primary membranous nephropathy with nephrotic syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference